Progression of Metabolic Dysfunction–Associated Steatohepatitis in US Adults Using Linked Records and Claims
Yestle Kim, Romina Fakhraei, John C O’Donnell, Karissa Johnston, Melissa Bather, Reem Mustafa, Andrew R Kennedy, Amreen Dinani · 2026
Read Progression of Metabolic Dysfunction–Associated Steatohepatitis in US Adults Using Linked Records and Claims by Yestle Kim, Romina Fakhraei, John C O’Donnell, Karissa Johnston, Melissa Bather, Reem Mustafa, Andrew R Kennedy, Amreen Dinani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13351128.txt.
Description
Yestle Kim and colleagues traced how fatty liver disease progresses to end-stage liver disease in United States adults in a 2026 records and claims study. Among 49,983 patients with the inflamed form of the disease, a third already had advanced liver damage at first record.
Of those without it, 15.9 percent progressed, with a median of just 10.6 months to the first severe event, most often decompensated cirrhosis. Use of non-invasive tests around diagnosis, predictors of decline, hospital use, and costs were all mapped. Such speed of progression argues for finding and treating these patients far earlier than current practice manages.
Catalog record
| CREATOR | Yestle Kim, Romina Fakhraei, John C O’Donnell, Karissa Johnston, Melissa Bather, Reem Mustafa, Andrew R Kennedy, Amreen Dinani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56131 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |